207 related articles for article (PubMed ID: 36445532)
1. Oncoinformatic screening of the gene clusters involved in the HER2-positive breast cancer formation along with the in silico pharmacodynamic profiling of selective long-chain omega-3 fatty acids as the metastatic antagonists.
Morshed AKMH; Al Azad S; Mia MAR; Uddin MF; Ema TI; Yeasin RB; Srishti SA; Sarker P; Aurthi RY; Jamil F; Samia NSN; Biswas P; Sharmeen IA; Ahmed R; Siddiquy M; Nurunnahar
Mol Divers; 2023 Dec; 27(6):2651-2672. PubMed ID: 36445532
[TBL] [Abstract][Full Text] [Related]
2. HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the "fat features" of the "Mediterranean diet" as an "anti-HER2 cocktail".
Menéndez JA; Vázquez-Martín A; Ropero S; Colomer R; Lupu R
Clin Transl Oncol; 2006 Nov; 8(11):812-20. PubMed ID: 17134970
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK
Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA.
Doughman SD; Krupanidhi S; Sanjeevi CB
Curr Diabetes Rev; 2007 Aug; 3(3):198-203. PubMed ID: 18220672
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway.
Wu M; Harvey KA; Ruzmetov N; Welch ZR; Sech L; Jackson K; Stillwell W; Zaloga GP; Siddiqui RA
Int J Cancer; 2005 Nov; 117(3):340-8. PubMed ID: 15900589
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 Polyunsaturated Fatty Acids Time-Dependently Reduce Cell Viability and Oncogenic MicroRNA-21 Expression in Estrogen Receptor-Positive Breast Cancer Cells (MCF-7).
LeMay-Nedjelski L; Mason-Ennis JK; Taibi A; Comelli EM; Thompson LU
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342901
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells.
Hammamieh R; Chakraborty N; Miller SA; Waddy E; Barmada M; Das R; Peel SA; Day AA; Jett M
Breast Cancer Res Treat; 2007 Jan; 101(1):7-16. PubMed ID: 16823509
[TBL] [Abstract][Full Text] [Related]
8. Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice.
Rose DP; Connolly JM; Coleman M
Clin Cancer Res; 1996 Oct; 2(10):1751-6. PubMed ID: 9816126
[TBL] [Abstract][Full Text] [Related]
9. Link between Omega 3 Fatty Acids Carried by Lipoproteins and Breast Cancer Severity.
Bobin-Dubigeon C; Nazih H; Croyal M; Bard JM
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745191
[TBL] [Abstract][Full Text] [Related]
10. Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).
Cocco E; Javier Carmona F; Razavi P; Won HH; Cai Y; Rossi V; Chan C; Cownie J; Soong J; Toska E; Shifman SG; Sarotto I; Savas P; Wick MJ; Papadopoulos KP; Moriarty A; Cutler RE; Avogadri-Connors F; Lalani AS; Bryce RP; Chandarlapaty S; Hyman DM; Solit DB; Boni V; Loi S; Baselga J; Berger MF; Montemurro F; Scaltriti M
Sci Signal; 2018 Oct; 11(551):. PubMed ID: 30301790
[TBL] [Abstract][Full Text] [Related]
11. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells.
Menendez JA; Lupu R; Colomer R
Eur J Cancer Prev; 2005 Jun; 14(3):263-70. PubMed ID: 15901996
[TBL] [Abstract][Full Text] [Related]
12. Target-specificity of different amyrin subunits in impeding HCV influx mechanism inside the human cells considering the quantum tunnel profiles and molecular strings of the CD81 receptor: a combined in silico and in vivo study.
Jabin A; Uddin MF; Al Azad S; Rahman A; Tabassum F; Sarker P; Morshed AKMH; Rahman S; Raisa FF; Sakib MR; Olive AH; Islam T; Tahsin R; Ahmed SZ; Biswas P; Habiba MU; Siddiquy M; Jafary M
In Silico Pharmacol; 2023; 11(1):8. PubMed ID: 36999133
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
Schley PD; Jijon HB; Robinson LE; Field CJ
Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the HER2 pathway by n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice.
Zou Z; Bellenger S; Massey KA; Nicolaou A; Geissler A; Bidu C; Bonnotte B; Pierre AS; Minville-Walz M; Rialland M; Seubert J; Kang JX; Lagrost L; Narce M; Bellenger J
J Lipid Res; 2013 Dec; 54(12):3453-63. PubMed ID: 24052576
[TBL] [Abstract][Full Text] [Related]
16. Dietary omega-3 fatty acids for women.
Bourre JM
Biomed Pharmacother; 2007; 61(2-3):105-12. PubMed ID: 17254747
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
[TBL] [Abstract][Full Text] [Related]
18. n-3 polyunsaturated fatty acids and HER2-positive breast cancer: interest of the fat-1 transgenic mouse model over conventional dietary supplementation.
Zou Z; Bidu C; Bellenger S; Narce M; Bellenger J
Biochimie; 2014 Jan; 96():22-7. PubMed ID: 24012777
[TBL] [Abstract][Full Text] [Related]
19. Understanding omega-3 polyunsaturated fatty acids.
Calder PC; Yaqoob P
Postgrad Med; 2009 Nov; 121(6):148-57. PubMed ID: 19940425
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
